5/1/2024- The Women’s Health Collaborative (WHC) officially launches what educational director Dr. Roberta Kline calls “the ultimate alliance of women’s health champions”. This united volunteer group consists of public resources for women’s cancer, dense breast advocacy, research foundations of complex disorders (ie. Endometriosis and pelvic floor issues) and medical specialists from the private sector. This coalition aligns the promotion of ultrasound technology as the common life-saving solution for affordable and effective medical screening programs.
In a recent “Cancer Powermeet” event, leading advocacy leader Ms. Barish joined the WHC concept about “EARLIER DETECTION” in support of proactive screenings for women from 20-39. “Due to the continuing rise in numbers of breast cancer cases in younger women, doctors need to change their thinking about starting checkups at 40.” Innovative screening plans comprise the use of ultrasound in screening centers and traveling vans as a starting point in underserved locations. For over 20 years, Ms. Barish has been active in state congress about a list of cancer related interests impacting women’s health including public initiatives like environmental causes and legislative change in healthcare protocols.
The outreach team behind the WHC aims to connect with lawmakers and health professionals alike, in pursuit of change through awareness. The Women’s Health Collaborative continues its mission to unite with new resources in support of better screening, community outreach and educational efforts to improve healthcare for women.
PROGRAM 1: EARLIER DETECTION
PROGRAM 2: DENSE BREAST SCREENING
REMEMBERING NANCY CAPPELLO: In 2014, Imaging Technology News (ITN) introduced breast cancer survivor-turned-crusader Dr. Nancy Cappello and her story about having dense breast tissue leading to a late-stage cancer. A false negative mammography scan (diagnosed in 2004) concealed a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer. This same cancer had metastasized to 13 lymph nodes. This sparked Dr. Cappello to create the "Are You Dense?" Foundation- an international awareness crusade to better support dense breast diagnostics and initiatives pass legislation to enact laws requiring mammography centers to inform patients about their breast density and the associated cancer risks. Dr. Cappello passed away on Nov 15, 2018, from secondary myelodysplastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments. But she ignited a legacy of fighting for improved policies, imaging technologies and advanced research to better address this health crisis that puts the est. 40% of the female population (women with dense breasts) at risk of a false negative reading.
PROGRAM 3: GENE TESTING FOR CANCER PREDISPOSITION
TEST- DON’T GUESS! CANCER PREDISPOSITION, HEREDITY & GENE TESTING
Most CANCERS are not directly caused by inherited gene mutations. Unlike traits and characteristics passed down to children like blood type and eye color, which are a direct result of genetics, chronic diseases like cancer are recognized to be the result of an interaction between your genetics and your environment. These genetic changes that increase the risk of cancer CAN be passed down or inherited.
When a specific cancer type is prevalent in one side of the family, the cancer is recognized as a FAMILIAL cancer. Many of them are caused by a genetic mutation in one or more genes related to cancer susceptibility, such as BRCA1 and breast cancer. This is also the case with a "family cancer syndrome" (or "hereditary cancer syndrome"), such as Lynch Syndrome, which is a rare disorder in which family members have an above-average chance of developing a certain type or types of cancer. It is reported that up to 10% of all cancer cases may be caused by specific inherited genetic mutations called CANCER PREDISPOSITION genes. Individuals who carry a mutant allele of these genes have an increased susceptibility to cancer. Research also shows that other types of genetic variations can also predispose to cancer including epigenetics. It is now widely identified that an accumulation of genetic or epigenetic alterations can affect the conversion of normal cells to cancer cells.
GET CHECKED NOW! If you have family members that have been diagnosed with cancer, you may want to consider a comprehensive genetic test to get your personal biological blueprint which includes your predisposition. Call today to speak to a genetic advisor for a free consultation at 212-355-7017. THE WOMEN'S HEALTH COLLABORATIVE is an all-volunteer support resource offering public awareness about health solutions for women. We are not a medical facility but are navigators in support of understanding the current resources available. We also provide public news, educational materials and information about the latest resources in specific health disorders. FOLLOW US ON LINKEDIN and subscribe to the Women's Health Newsletter!
"TEST, DON'T GUESS!"- Cancer Predisposition & the Role of Genetic Testing By: Dr. Roberta Kline Cancer comes from one of two ways: inheriting genetic mutations that significantly increase your risk for specific types of cancer- but the majority of cancers occur from an interaction between your individual genes and the environment that they've been exposed to throughout your lifetime. Both of them can be tested for. And if you know what you're dealing with, you can create a plan that's specific for you that enables you to be proactive. This enables you to have that locus of control, that you know what's going on in your body, but you don't know if you don't test. Therefore, TEST- DON'T GUESS! And then you can create your roadmap that works for you.
VIDEO SPOTLIGHT: Cancer Science News features Dr. Ben Ho Park on EARLIER DETECTION & THE TYPES OF BREAST CANCERS Ben Ho Park, MD, PhD, is Director of the Vanderbilt-Ingram Cancer Center (VICC). Dr. Park is also a Professor of Medicine in the Department of Medicine's Division of Hematology and Oncology. Dr. Park's research is dedicated to finding a cure for all types of breast cancer by investigating mutated and altered genes responsible for the development and progression of breast cancer, as well as genes that lead to drug resistance. He is actively involved with the VICC Breast Cancer Research Program’s clinical research team to translate his research into clinical practice and patient care. (Complete interview & feature story) |